Immunohistochemical markers in evaluation of urinary and bladder tumors

Analytical and Quantitative Cytology and Histology

Volumn 29, Issue 2, 2007, Pages 121-122

  Lopez Beltran, Antonio ^a  

^a Universidad de Cordoba   (Spain)

Author keywords

Immunohistochemical marker; Tumor, bladder; Tumor, urinary

Indexed keywords

CYCLIN D1; CYCLIN D3; PROTEIN P53; TRANSCRIPTION FACTOR E2F1; TUMOR MARKER;

BLADDER CARCINOMA; DIAGNOSTIC VALUE; DISEASE MARKER; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LETTER; PRIORITY JOURNAL; PROGNOSIS;

CYCLINS; HUMANS; IMMUNOHISTOCHEMISTRY; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER NEOPLASMS;

EID: 34247477610     PISSN: 08846812     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (13)

1. Emerson RE, Cheng L: Immunohistochemical markers in the evaluation of tumors of the urinary bladder: A review. Anal Quant Cytol Histol 2005;27:301-316
2. Bollito ER, Paccioni D, Lopez-Beltran A, Volante M, Terrone C, Casetta G, Mari M, DePompa R, Cappia S, Papotti M: Immunohistochemical study of neuroendocrine differentiation in primary glandular lesions and tumors of the urinary bladder. Anal Quant Cytol Histol 2005;27:218-224
3. Lopez-Beltran A, MacLennan GT, Montironi R: Cyclin E as molecular marker of breast cancer: A review. Anal Quant Cytol Histol 2006;28:111-114
4. Mazzuccheli R, Barbisan F, Tarquini LM, Streccioni M, Galosi AB: Urothelial changes induced by therapeutic procedures for bladder cancer: A review. Anal Quant Cytol Histol 2005; 27:27-34
5. Scartozzi M, Pierantoni C, Berardi R, Antognoli S, Bearzi I, Cascinu S: Epidermal growth factor receptor: A promising therapeutic target for colorectal cancer. Anal Quant Cytol Histol 2006;28:69-77
6. Kipp BR, Fritcher EG, del Rosario KM, Stevens CL, Sebo TJ, Hallings KC: A systematic approach to identifying urothelial cells likely to be polysomic by fluorescence in situ hybridization. Anal Quant Cytol Histol 2005;27:317-322
7. Mazzuccheli R, Barbisan F, Stramazzoti D, Montironi R, Lopez-Beltran A, Scarpelli M: Chromosomal abnormalities in macroscopically normal urothelium in patients with pT1 and pT2a urothelial carcinoma: A fluorescence in situ hybridization study and correlation with histologic features. Anal Quant Cytol Histol 2005;27:143-151
8. Kiroudy-Voulgari A, Kouloukoussa M, Simigiatos C, Karakitsos P, Zervas A, Kittas C, Mitropoulos D: DNA ploidy and immunomarking of bladder urothelial tumors before and after intravesicle bacillus Calmette-Guerin treatment. Anal Quant Cytol Histol 2005;27:52-60
9. Iczkowski KA, Butler SL: New immunohistochemical markers in testicular tumors. Anal Quant Cytol Histol 2006;28:181-187
10. Aldey BP, Papavero V, Sugimura J, The BT, Yang XL: Diagnostic value of cytokeratin 7 and parvalbumin in differentiating chromophobe renal cell carcinoma from renal oncocitoma. Anal Quant Cytol Histol 2006;28:228-236
11. Lopez-Beltran A, Luque RJ, Alvarez-Kindelan J, Quintero A, Merlo F, Requena M, M, Montironi R: Prognostic factors in survival of patients with stage Ta and T1 bladder urothelial tumors: The role of G1-S modulators (p53, p21Waf1, p27Kip1, cyclin D1, and cyclin D3), proliferation index, and clinicopathologic parameters. Am J Clin Pathol 2004;122:444-452
12. Lopez-Beltrana A, Luque RJ, Alvarez-Kindelan J, Quintero A, Merlo F, Carrasco JC, Requena M, Montironi R: Prognostic factors in stageT1 grade 3 bladder cancer survival: The role of G1-S modulators (p53, p21Waf1, p27kip1, cyclin D1, and cyclin D3) and proliferation index (ki67-MIB1). Eur Urol 2004;45:606-612
13. Lopez-Beltran A, Requena MJ, Luque RJ, Alvarez-Kindelan J, Quintero A, Blanca AM, Rodriguez ME, Siendones E, Montironi R: Cyclin D3 expression in primary Ta/T1 bladder cancer. J Pathol 2006;209:106-113